Near-euglycemia can be achieved safely in pediatric total pancreatectomy islet autotransplant recipients using an adapted intravenous insulin infusion protocol

Diabetes Technology and Therapeutics

Volumn 16, Issue 11, 2014, Pages 706-713

  Forlenza, Gregory P ^a   Chinnakotla, Srinath ^a   Schwarzenberg, Sarah J ^a   Cook, Marie ^a   Radosevich, David M ^a   Manchester, Carol ^b   Gupta, Sameer ^a   Nathan, Brandon ^a   Bellin, Melena D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ARTICLE; AUTOGRAFT; CHILD; CHRONIC PANCREATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; MALE; MEDICAL RECORD REVIEW; PANCREAS RESECTION; PEDIATRIC SURGERY; TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION; CLINICAL PROTOCOL; DIABETES MELLITUS, TYPE 1; GLUCOSE CLAMP TECHNIQUE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PANCREAS ISLET TRANSPLANTATION; PANCREATITIS, CHRONIC; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; AUTOGRAFTS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN INFUSION SYSTEMS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; PANCREATECTOMY; PANCREATITIS, CHRONIC; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84911900246     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0061     Document Type: Article

References (34)

1. Bellin MD, Sutherland DE: Pediatric islet autotransplantation: indication, technique, and outcome. Curr Diab Rep 2010;10:326-331.
2. Blondet JJ, Carlson AM, Kobayashi T, Jie T, Bellin M, Hering BJ, Freeman ML, Beilman GJ, Sutherland DE: The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am 2007;87: 1477-1501,
3. Sutherland DE, Radosevich DM, Bellin MD, Hering BJ, Beilman GJ, Dunn TB, Chinnakotla S, Vickers SM, Bland B, Balamurugan AN, Freeman ML, Pruett TL: Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg 2012;214:409-424; discussion 424-426.
4. Sutherland DE, Gruessner AC, Carlson AM, Blondet JJ, Balamurugan AN, Reigstad KF, Beilman GJ, Bellin MD, Hering BJ: Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 2008;86:1799-1802.
5. Ahmad SA, Lowy AM, Wray CJ, D'Alessio D, Choe KA, James LE, Gelrud A, Matthews JB, Rilo HL: Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg 2005;201:680-687.
6. Wilson GC, Sutton JM, Salehi M, Schmulewitz N, Smith MT, Kucera S, Choe KA, Brunner JE, Abbott DE, Sussman JJ, Ahmad SA: Surgical outcomes after total pancreatectomy and islet cell autotransplantation in pediatric patients. Surgery 2013;154:777-783; discussion 783-754.
7. Hathout E, Chan NK, Tan A, Sakata N, Mace J, Pearce W, Peverini R, Chinnock R, Sowers L, Obenaus A: In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Pediatr Transplant 2009;13:892-897.
8. Speier S, Nyqvist D, Cabrera O, Yu J, Molano RD, Pileggi A, Moede T, Kohler M, Wilbertz J, Leibiger B, Ricordi C, Leibiger IB, Caicedo A, Berggren PO: Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 2008; 14:574-578.
9. Finzi G, Davalli A, Placidi C, Usellini L, La Rosa S, Folli F, Capella C: Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultrastruct Pathol 2005;29:525-533.
10. Nacher V, Merino JF, Raurell M, Soler J, Montanya E: Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. Diabetes 1998;47:192-196.
11. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E: Beta-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 2002;51:66-72.
12. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC: Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996;45:1161-1167.
13. Juang JH, Bonner-Weir S, Wu YJ, Weir GC: Beneficial influence of glycemic control upon the growth and function of transplanted islets. Diabetes 1994;43:1334-1339.
14. Jimbo T, Inagaki A, Imura T, Sekiguchi S, Nakamura Y, Fujimori K, Miyagawa J, Ohuchi N, Satomi S, Goto M: A novel resting strategy for improving islet engraftment in the liver. Transplantation 2014;97:280-286.
15. Merino JF, Nacher V, Raurell M, Biarnes M, Soler J, Montanya E: Optimal insulin treatment in syngeneic islet transplantation. Cell Transplant 2000;9:11-18.
16. Ferrer-Garcia JC, Merino-Torres JF, Perez Bermejo G, Herrera-Vela C, Ponce-Marco JL, Pinon-Selles F: Insulininduced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice. Cell Transplant 2003;12:849-857.
17. Bellin MD, Sutherland DE, Chinnakotla S, Dunn T, Kim Y, Johnson J, Saeed A, Manchester C, Balamurugan AN, Hering BJ, Pruett TL, Beilman GJ: Insulin independence after islet autotransplant is associated with subtle differences in early post-transplant glycemic control [abstract]. Diabetes 2012;61(Suppl 1):A43.
18. Ahmann AJ, Maynard G: Designing and implementing insulin infusion protocols and order sets. J Hosp Med 2008; 3(5 Suppl):42-54.
19. Dilkhush D, Lannigan J, Pedroff T, Riddle A, Tittle M: Insulin infusion protocol for critical care units. Am J Health Syst Pharm 2005;62:2260-2264.
20. Wilson M, Weinreb J, Hoo GW: Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007;30:1005-1011.
21. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists, American Diabetes Association: Ameri can Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-1131.
22. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ: Towards a feasible algorithm for tight glycaemic control in critically ill patients: A systematic review of the literature. Crit Care 2006;10:R19.
23. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-360; discussion 360-362.
24. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-1021.
25. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
26. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
27. NICE-SUGAR Study Investigators, Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG: Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367:1108-1118.
28. Magaji V, Nayak S, Donihi AC, Willard L, Jampana S, Nivedita P, Eder R, Johnston J, Korytkowski MT: Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery. Diabetes Technol Ther 2012;14:1013-1017.
29. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G: Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009;373:547-556.
30. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-467.
31. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, Rajotte RV: Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999;8:285-292.
32. Ricordi C, Lacy PE, Scharp DW: Automated islet isolation from human pancreas. Diabetes 1989;38(Suppl 1): 140-142.
33. Alonso LC, Yokoe T, Zhang P, Scott DK, Kim SK, O'Donnell CP, Garcia-Ocana A: Glucose infusion in mice: A new model to induce beta-cell replication. Diabetes 2007; 56:1792-1801.
34. Martens GA, Pipeleers D: Glucose, regulator of survival and phenotype of pancreatic beta cells. Vitam Horm 2009; 80:507-539.